Associate Professor

Graeme Macdonald

Email: 
Phone: 
+61 7 3176 2613

Availability

Associate Professor Graeme Macdonald is:
Available for supervision
Media expert

Qualifications

  • Royal Australasian College of Physicians, Royal Australasian College of Physicians

Search Professor Graeme Macdonald’s works on UQ eSpace

281 works between 1994 and 2025
All (281) Journal Article (156) Book Chapter (5) Conference Publication (120)

121 - 140 of 281 works

2014

Journal Article

Resveratrol does not benefit patients with non-alcoholic fatty liver disease

Chachay, Veronique S., Macdonald, Graeme A., Martin, Jennifer H., Whitehead, Jonathan P., O’Moore-Sullivan, Trisha M., Lee, Paul, Franklin, Michael, Klein, Kerenaftali, Taylor, Paul J., Ferguson, Maree, Coombes, Jeff S., Thomas, Gethin P., Cowin, Gary J., Kirkpatrick, Carl M. J., Prins, Johannes B. and Hickman, Ingrid J. (2014). Resveratrol does not benefit patients with non-alcoholic fatty liver disease. Clinical Gastroenterology and Hepatology, 12 (12), 2092-2103.e6. doi: 10.1016/j.cgh.2014.02.024

Resveratrol does not benefit patients with non-alcoholic fatty liver disease

2014

Journal Article

Total body fat and the risk of Barrett's oesophagus - A bioelectrical impedance study

Kendall, Bradley J., Macdonald, Graeme A., Prins, Johannes B., O'Brien, Suzanne and Whiteman, David C. (2014). Total body fat and the risk of Barrett's oesophagus - A bioelectrical impedance study. Cancer Epidemiology, 38 (3), 266-272. doi: 10.1016/j.canep.2014.03.006

Total body fat and the risk of Barrett's oesophagus - A bioelectrical impedance study

2014

Conference Publication

Fat oxidation over a range of exercise intensities: fitness versus fatness

Croci, Ilaria, Hickman, Ingrid J., Wood, Rachel E., Borrani, Fabio, Macdonald, Graeme A. and Byrne, Nuala M. (2014). Fat oxidation over a range of exercise intensities: fitness versus fatness. 6th Exercise and Sport Science Australia Conference, Adelaide, SA, Australia, 10-12 April 2014.

Fat oxidation over a range of exercise intensities: fitness versus fatness

2014

Conference Publication

Pre-operative cardiorespiratory fitness and post-operative cardiometabolic disease in liver transplant recipients

Wallen, M. P., Woodward, A., Skinner, T. L., Macdonald, G. A. and Coombes, J. S. (2014). Pre-operative cardiorespiratory fitness and post-operative cardiometabolic disease in liver transplant recipients. Australian Gastroenterology Week 2014, Broadbeach, QLD Australia, 22-24 October 2014. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12736_5

Pre-operative cardiorespiratory fitness and post-operative cardiometabolic disease in liver transplant recipients

2014

Conference Publication

Hepatic fibrosis is associated with small intestinal permeability in chronic liver disease due to hepatitis C, hepatitis B and non-alcoholic fatty liver disease, in subjects without ascites. A prospective cohort study using non-invasive techniques

Raj, Ashok, Holtmann, Gerald, Bhat, Purnima, Fletcher, Linda, Tran, Cuong, Vesey, David and Macdonald, Graeme (2014). Hepatic fibrosis is associated with small intestinal permeability in chronic liver disease due to hepatitis C, hepatitis B and non-alcoholic fatty liver disease, in subjects without ascites. A prospective cohort study using non-invasive techniques. Asian Pacific Digestive Week, Bali, Indonesia, 22‐25, 2014. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia . doi: 10.1111/jgh.12766_2

Hepatic fibrosis is associated with small intestinal permeability in chronic liver disease due to hepatitis C, hepatitis B and non-alcoholic fatty liver disease, in subjects without ascites. A prospective cohort study using non-invasive techniques

2013

Journal Article

Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease

Croci, Ilaria, Byrne, Nuala M., Choquette, Stephane, Hills, Andrew P., Chachay, Veronique S., Clouston, Andrew D., O'Moore-Sullivan, Trisha M., Macdonald, Graeme A., Prins, Johannes B. and Hickman, Ingrid J. (2013). Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease. Gut, 62 (11), 1625-1633. doi: 10.1136/gutjnl-2012-302789

Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease

2013

Journal Article

A Pilot Randomised Study of the Metabolic and Histological Effects of Exercise in Non-alcoholic Steatohepatitis

Hickman, Ingrid J., Byrne, Nuala M., Croci, Ilaria, Chachay, Veronique S., Clouston, Andrew D., Hills, Andrew P., Bugianesi, Elisabetta, Whitehead, Jonathan P, Gastaldelli, Amalia, O'Moore-Sullivan, Trisha M., Prins, Johannes B. and Macdonald, Graeme A . (2013). A Pilot Randomised Study of the Metabolic and Histological Effects of Exercise in Non-alcoholic Steatohepatitis. Journal of Diabetes and Metabolism, 4 (8) 8. doi: 10.4172/2155-6156.1000300

A Pilot Randomised Study of the Metabolic and Histological Effects of Exercise in Non-alcoholic Steatohepatitis

2013

Conference Publication

Advanced Hepatic Fibrosis Is Associated With Increased Small Intestinal Permeability: A Novel Evaluation Incorporating a Plasma-Based Assay and Transient Elastography

Raj, Ashok, Macdonald, Graeme A., Bhat, Purnima, Tran, Cuong D. and Holtmann, Gerald (2013). Advanced Hepatic Fibrosis Is Associated With Increased Small Intestinal Permeability: A Novel Evaluation Incorporating a Plasma-Based Assay and Transient Elastography. Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Orlando Florida, 18 - 21 May, 2013. Philadelphia, United States of America: Elsevier Inc..

Advanced Hepatic Fibrosis Is Associated With Increased Small Intestinal Permeability: A Novel Evaluation Incorporating a Plasma-Based Assay and Transient Elastography

2013

Journal Article

The risk of Barrett's esophagus associated with abdominal obesity in males and females

Kendall, Bradley J., Macdonald, Graeme A., Hayward, Nicholas K., Prins, Johannes B., O'Brien, Suzanne, Whiteman, David C., Study of Digestive Health, Green. Adele C., Parsons, Peter G., Pavey, Sandra J., Purdie, David M. and Webb, Penelope M. (2013). The risk of Barrett's esophagus associated with abdominal obesity in males and females. International Journal of Cancer, 132 (9), 2192-2199. doi: 10.1002/ijc.27887

The risk of Barrett's esophagus associated with abdominal obesity in males and females

2013

Conference Publication

Obstructive Sleep Apnea, Gastroesophageal Reflux and Barrett's Esophagus in a Population-Based Case-Control Study

Lindam, Anna P., Kendall, Bradley J., Thrift, Aaron P., Macdonald, Graeme A., Lagergren, Jesper and Whiteman, David C. (2013). Obstructive Sleep Apnea, Gastroesophageal Reflux and Barrett's Esophagus in a Population-Based Case-Control Study. Digestive Disease Week / 28th Annual Residents and Fellows Research Conference of the Society-for-Surgery-of-the-Alimentary-Tract (SSAT), Orlando Fl, May 18-21, 2013. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC.

Obstructive Sleep Apnea, Gastroesophageal Reflux and Barrett's Esophagus in a Population-Based Case-Control Study

2013

Journal Article

Use of standardised assessment forms in referrals to hepatology outpatient services: implications for accurate triaging of patients with chronic hepatitis C

Horsfall, Leigh, Macdonald, Graeme, Scott, Ian, Skoien, Richard, Khatun, Mohsina, Moss, Cathy, Seligman, Clare, Kardash, Christine, Poxon, Vicki and Powell, Elizabeth E. (2013). Use of standardised assessment forms in referrals to hepatology outpatient services: implications for accurate triaging of patients with chronic hepatitis C. Australian Health Review, 37 (2), 218-222. doi: 10.1071/AH12162

Use of standardised assessment forms in referrals to hepatology outpatient services: implications for accurate triaging of patients with chronic hepatitis C

2013

Conference Publication

Trends in treatment of recurrent hepatitis C after liver transplantation

Forgan-Smith, K. R., Stuart, K. A., Tallis, C., Macdonald, G. A. and Fawcett, J. (2013). Trends in treatment of recurrent hepatitis C after liver transplantation. The Australian Gastroenterology Week 2013, Melbourne, VIC Australia, 7 - 9 October 2013. Richmond, VIC 3121 Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12365_14

Trends in treatment of recurrent hepatitis C after liver transplantation

2013

Conference Publication

Abdominal obesity and Barrett's oesophagus - does hip obesity reduce the risk?

Kendall, B. J., Macdonald, G. A., Prins, J. B., O'Brien, S. and Whiteman, D. C. (2013). Abdominal obesity and Barrett's oesophagus - does hip obesity reduce the risk?. Australian Gastroenterology Week 2013, Melbourne Australia, 7-9 October 2013. Richmond Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12365_7

Abdominal obesity and Barrett's oesophagus - does hip obesity reduce the risk?

2013

Conference Publication

Treatment of hepatitis c genotype 1 patients with severe fibrosis or compensated cirrhosis: The telaprevir early access program in patients from Australia and New Zealand

Macdonald, G. A., Roberts, S. K., Dore, G. J., Gane, E. J., Thompson, A. J., Weltman, M. D., Weilert, F., Hill, A., Laeuffer, J. and Strasser, S. I. (2013). Treatment of hepatitis c genotype 1 patients with severe fibrosis or compensated cirrhosis: The telaprevir early access program in patients from Australia and New Zealand. The Australian Gastroenterology Week 2013, Melbourne, VIC Australia, 7 - 9 October 2013. Richmond, VIC 3121 Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12365_14

Treatment of hepatitis c genotype 1 patients with severe fibrosis or compensated cirrhosis: The telaprevir early access program in patients from Australia and New Zealand

2013

Conference Publication

Management and outcomes of side effects with focus on anaemia in patients with hepatitis c genotype 1 infection: The telaprevir early access program in patients from Australia and New Zealand

Strasser, S. I., Roberts, S. K., Gane, E. J., Macdonald, G. A., Thompson, A. J., Weltman, M. D., Weilert, F., Hill, A., Laeuffer, J. and Dore, G. J. (2013). Management and outcomes of side effects with focus on anaemia in patients with hepatitis c genotype 1 infection: The telaprevir early access program in patients from Australia and New Zealand. The Australian Gastroenterology Week 2013, Melbourne, VIC Australia, 7 - 9 October 2013. Richmond, VIC 3121 Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12365_14

Management and outcomes of side effects with focus on anaemia in patients with hepatitis c genotype 1 infection: The telaprevir early access program in patients from Australia and New Zealand

2013

Book Chapter

Physical activity and cardiovascular fitness in patients with NAFLD: Clinical importance and therapeutic implications

Hickman, Ingrid J., Macdonald, Graeme A. and Byrne, Nuala M. (2013). Physical activity and cardiovascular fitness in patients with NAFLD: Clinical importance and therapeutic implications. Non-alcoholic fatty liver disease : A practical guide. (pp. 132-148) Chichester, W Sussex, U,K.: Wiley-Blackwell. doi: 10.1002/9781118556153.ch12

Physical activity and cardiovascular fitness in patients with NAFLD: Clinical importance and therapeutic implications

2013

Conference Publication

Significant hepatic fibrosis is associated with increased small intestinal permeability

Raj, A. S., Macdonald, G. A., Bhat, P., Fletcher, L. M., Tran, C., Black, M. and Holtmann, G. (2013). Significant hepatic fibrosis is associated with increased small intestinal permeability. The Australian Gastroenterology Week 2013, Melbourne, VIC Australia, 7 - 9 October 2013. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12365_5

Significant hepatic fibrosis is associated with increased small intestinal permeability

2013

Conference Publication

Investigating the clinical effect of resveratrol in non-alcoholic fatty liver disease: a randomised, double blind, placebo-controlled trial

Chachay, V. S., Martin, J. H., Prins, J. B., Whitehead, J. P., O'Moore-Sullivan, T. M., Lee, P., Franklin, M., Klein, K., Taylor, P. J., Ferguson, M., Coombes, J. S., Thomas, G. P., Cowin, G. J., Kirkpatrick, C. M. J., Macdonald, G. A. and Hickman, I. J. (2013). Investigating the clinical effect of resveratrol in non-alcoholic fatty liver disease: a randomised, double blind, placebo-controlled trial. Australian Gastroenterology Week 2013, Melbourne, VIC, Australia, 7-9 October 2013. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/jgh.12365_5

Investigating the clinical effect of resveratrol in non-alcoholic fatty liver disease: a randomised, double blind, placebo-controlled trial

2012

Journal Article

The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis

Tan, Terrence C. H., Crawford, Darrell H. G., Franklin, Michael E., Jaskowski, Lesley A., Macdonald, Graeme A., Jonsson, Julie R., Watson, Melanie J., Taylor, Paul J. and Fletcher, Linda M. (2012). The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis. Liver International, 32 (9), 1391-1399. doi: 10.1111/j.1478-3231.2012.02828.x

The serum hepcidin:ferritin ratio is a potential biomarker for cirrhosis

2012

Journal Article

Hepatitis C treatment outcomes in Australian clinics

Gidding, Heather F., Law, Matthew G., Amin, Janaki, Ostapowicz, George, Weltman, Martin, Macdonald, Graeme A., Sasadeusz, Joe J., Haber, Paul A. W., George, Jacob and Dore, Gregory J. (2012). Hepatitis C treatment outcomes in Australian clinics. Medical Journal of Australia, 196 (10), 633-637. doi: 10.5694/mja12.10014

Hepatitis C treatment outcomes in Australian clinics

Current funding

  • 2020 - 2025
    Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network Study
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant

Past funding

  • 2020 - 2022
    Liver targeted Interleukin-22 for the treatment of non-alcoholic steatohepatitis
    NHMRC IDEAS Grants
    Open grant
  • 2018 - 2019
    IL-22-based therapy ameliorates liver steatosis
    Gastroenterological Society of Australia
    Open grant
  • 2018 - 2021
    Evaluation of a telehealth-supported hepatitis C treatment model of care for Indigenous Health Services
    Queensland Health
    Open grant
  • 2014
    Cellular metabolic respirometry and enzymatic assessment suite
    UQ Major Equipment and Infrastructure
    Open grant
  • 2013 - 2014
    The role of gut bacterial and mucosal permeability in liver injury
    PA Research Foundation
    Open grant
  • 2012 - 2014
    HFE-associated Steatohepatitis: Mechanisms and Therapies
    NHMRC Project Grant
    Open grant
  • 2009 - 2010
    New ways to improve cardiovascular function by modulating the hormone adiponectin
    National Heart Foundation of Australia
    Open grant
  • 2009 - 2012
    Pharmacodynamics in Liver Disease and in Liver Surgery
    NHMRC Project Grant
    Open grant
  • 2008 - 2012
    Obesity-related inflammation and insulin resistance in chronic liver disease: exercise and diet as treatment options
    NHMRC Project Grant
    Open grant
  • 2007 - 2010
    Clinical measures of obesity & risk of Barrett's oesophagus
    Queensland Health Smart Health Research Grant
    Open grant
  • 2007
    Adiponectin: linking obesity and cardiovascular disease
    Cardiovasular Lipid Research Grants Pfizer Australia
    Open grant
  • 2006 - 2008
    Adiponectin - Multimerization, Secretion and Action
    NHMRC Project Grant
    Open grant
  • 2006
    Metabolic complications of liver transplantation
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2005
    The relationship betwen serum adiponectin and inflammatory state in obese adults
    Princess Alexandra Hospital R&D Foundation
    Open grant
  • 2003 - 2004
    Protocol NV17317 - Peginterferon alfa-2a & Ribavirin
    Roche Products Pty Ltd
    Open grant
  • 2003 - 2005
    Human Hepatic Insulin Resistance
    NHMRC Project Grant
    Open grant
  • 2003
    NV-02B-007 A randomized, double blind trial of LdT (Telbivudine) versus Lamivudine in adults with compensated chronic hepatitis B
    Quintiles Pty Ltd
    Open grant
  • 2002
    Symptom impact for people living with haemophilia and hepatitis C
    Haemophilia Foundation Research Fund
    Open grant
  • 2001 - 2002
    Insulin sensitivity and hepatic steatosis
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2001
    Insulin sensitivity and hepatic steatosis.
    UQ Early Career Researcher
    Open grant
  • 1999 - 2000
    Regulation of basal and insulin-stimulated glucose uptake in human muscle, liver and omental and subcutaneous adipose tissues
    Wesley Merdical Research
    Open grant
  • 1999
    The assessment of candidate tumor suppressor genes in hepatocellular carcinoma
    UQ Early Career Researcher
    Open grant

Availability

Associate Professor Graeme Macdonald is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Master Philosophy

    Assessment of muscle mass hepatic function and outcomes in patients awaiting liver transplantation

    Principal Advisor

    Other advisors: Professor Jeff Coombes

  • Doctor Philosophy

    The clinical utility of measuring sarcopenia, myosteatosis and frailty in the nutrition assessment of patients referred for liver transplantation.

    Associate Advisor

    Other advisors: Dr Hannah Mayr, Associate Professor Ingrid Hickman

Completed supervision

Enquiries

Contact Associate Professor Graeme Macdonald directly for media enquiries about:

  • Adiponectin
  • Hepatitis
  • Illness and quality of life
  • Insulin resistance
  • Liver disease
  • Metabolic syndrome
  • Quality of life and illness
  • Steatohepatitis
  • Viral hepatitis

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au